Zimmer Biomet (ZBH)
(Delayed Data from NYSE)
$111.29 USD
+0.65 (0.59%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $111.30 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Brokerage Reports
0 items in cart
Zimmer Biomet Holdings, Inc. [ZBH]
Reports for Purchase
Showing records 21 - 40 ( 196 total )
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for ZBH 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
3Q23 Solid, but Not Enough To Offset Market Concerns
Provider: Roth Capital Partners, Inc.
Analyst: WITTES J
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Initiate with Neutral and $120 Price Target
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Company: Zimmer Biomet Holdings, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department